Update on the Biopharmaceutical Industry’s Commitment to Beat COVID-19: Therapeutics Development
Please join Dr. Andrew Adams of Eli Lilly, Dr. Julie Gerberding of Merck and Dr. Mike Ybarra of PhRMA for a discussion on the biopharmaceutical industry’s efforts to develop therapeutics for COVID-19.
Registration is closed. This event has already been held.
Update on the Biopharmaceutical Industry’s Commitment to Beat COVID-19: Therapeutics DevelopmentViewing information to be shared on 2/8